Wearable Electrical Stimulation for Spinal Cord Injury
(RISES-T Trial)
Trial Summary
What is the purpose of this trial?
The goal of this study is to evaluate if non-invasive electrical spinal stimulation can help people with paralysis caused by SCI improve strength and function of their arms, legs, hands or feet. The study will involve therapy sessions involving exercises done at the same time as electrical stimulation therapy. This study has multiple parts to evaluate the effectiveness and safety of "smart" electrical stimulation of the spinal cord, which involves stimulating the spinal cord at precise locations and times to improve movement and function.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the study team to get a clear answer.
What data supports the effectiveness of the treatment Occupational/Physical Therapy, RISES-T System for spinal cord injury?
Research shows that electrical stimulation can help improve muscle strength, endurance, and overall function in people with spinal cord injuries. It has been used to restore walking ability and improve other bodily functions, suggesting potential benefits for the RISES-T System in similar contexts.12345
Is wearable electrical stimulation safe for humans with spinal cord injury?
How does the RISES-T System treatment differ from other treatments for spinal cord injury?
The RISES-T System is unique because it involves wearable electrical stimulation, which is a non-invasive method that can be used to enhance voluntary control of muscles in individuals with spinal cord injury. Unlike traditional methods, this system may offer a more flexible and adaptive approach to rehabilitation by using real-time, spatially selective stimulation to improve motor function.134710
Research Team
Mijail D Serruya, MD, PhD
Principal Investigator
Thomas Jefferson University
Eligibility Criteria
This trial is for individuals with non-progressive spinal cord injuries from C2-T10, at least one year post-injury, and classified as B, C, or D on the ASIA scale. Participants must be able to consent and engage in physical therapy with caregiver support. It's not suitable for those with severe cardiopulmonary disease, unexcitable muscles due to lower motor neuron injury, severe neuropathic pain or cognitive disorders, skin breakdown where electrodes are placed, active implanted devices or pregnancy.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Participants complete a baseline assessment of outcome measures and undergo mapping with sensors to characterize their motor signature
Open-loop SCS Phase
Participants undergo 15 open-loop transcutaneous spinal cord stimulation sessions combined with functional task practice
Closed-loop SCS Phase
Participants undergo 15 closed-loop transcutaneous spinal cord stimulation sessions combined with functional task practice
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Occupational/Physical Therapy
- RISES-T System
Find a Clinic Near You
Who Is Running the Clinical Trial?
Thomas Jefferson University
Lead Sponsor
Kessler Foundation
Collaborator